Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| 1 |
Broadcom
AVGO
|
$2.09B |
| 2 |
Mastercard
MA
|
$2.06B |
| 3 |
UnitedHealth
UNH
|
$1.3B |
| 4 |
Coca-Cola
KO
|
$1.17B |
| 5 |
Marsh & McLennan
MMC
|
$1.1B |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
$1.55B |
| 2 |
Apple
AAPL
|
$1.51B |
| 3 |
JPMorgan Chase
JPM
|
$1.34B |
| 4 |
General Dynamics
GD
|
$1.25B |
| 5 |
Wells Fargo
WFC
|
$1.17B |
Sector Composition
| 1 | Technology | 21.49% |
| 2 | Healthcare | 18.42% |
| 3 | Financials | 15.97% |
| 4 | Consumer Discretionary | 9.49% |
| 5 | Industrials | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SLRN
1726
DELISTED
ACELYRIN
SLRN
| $443K | ﹤0.01% |
179,150
-1,389
| -0.8% | -$3.43K |
|
1727
Innoviva
INVA
$1.29B
| $442K | ﹤0.01% |
+24,397
| New | +$442K |
|
1728
IAC Inc
IAC
$2.98B
| $442K | ﹤0.01% |
11,733
-679
| -5% | -$25.6K |
|
1729
Syndax Pharmaceuticals
SNDX
$1.47B
| $442K | ﹤0.01% |
35,962
-4,198,493
| -99% | -$51.6M |
|
1730
Blue Owl Capital
OWL
$11.6B
| $428K | ﹤0.01% |
+21,377
| New | +$428K |
|
1731
Immunovant
IMVT
$2.99B
| $428K | ﹤0.01% |
25,030
-1,239
| -5% | -$21.2K |
|
1732
Compass Therapeutics
CMPX
$590M
| $423K | ﹤0.01% |
+222,505
| New | +$423K |
|
1733
Novavax
NVAX
$1.28B
| $419K | ﹤0.01% |
65,293
+755
| +1% | +$4.84K |
|
1734
Invesco
IVZ
$9.81B
| $418K | ﹤0.01% |
+27,566
| New | +$418K |
|
1735
Lazard
LAZ
$5.32B
| $417K | ﹤0.01% |
+9,636
| New | +$417K |
|
1736
Molson Coors Class B
TAP
$9.96B
| $416K | ﹤0.01% |
6,839
+1,670
| +32% | +$102K |
|
1737
Lear
LEA
$5.91B
| $405K | ﹤0.01% |
4,589
+880
| +24% | +$77.6K |
|
1738
Neurogene
NGNE
$285M
| $403K | ﹤0.01% |
34,421
+12,704
| +58% | +$149K |
|
1739
Clearway Energy Class A
CWEN.A
$3.2B
| $400K | ﹤0.01% |
+14,070
| New | +$400K |
|
1740
Kellanova
K
$27.8B
| $398K | ﹤0.01% |
+4,828
| New | +$398K |
|
1741
Arrow Electronics
ARW
$6.57B
| $397K | ﹤0.01% |
3,823
-277
| -7% | -$28.8K |
|
1742
Iovance Biotherapeutics
IOVA
$901M
| $396K | ﹤0.01% |
119,008
+1,582
| +1% | +$5.27K |
|
1743
Graham Holdings Company
GHC
$4.93B
| $390K | ﹤0.01% |
406
| – | – |
|
1744
Vail Resorts
MTN
$5.87B
| $383K | ﹤0.01% |
2,394
+1,197
| +100% | +$192K |
|
1745
Dyne Therapeutics
DYN
$2.02B
| $380K | ﹤0.01% |
36,322
-2,228
| -6% | -$23.3K |
|
1746
Foghorn Therapeutics
FHTX
$326M
| $376K | ﹤0.01% |
102,888
+15,819
| +18% | +$57.7K |
|
1747
CenterPoint Energy
CNP
$24.7B
| $365K | ﹤0.01% |
10,082
-3,194,413
| -100% | -$116M |
|
1748
iShares Russell Mid-Cap ETF
IWR
$44.6B
| $357K | ﹤0.01% |
4,200
| – | – |
|
1749
Kohl's
KSS
$1.86B
| $350K | ﹤0.01% |
+42,795
| New | +$350K |
|
|
TECX
1750
Tectonic Therapeutic, Inc. Common Stock
TECX
$314M
| $348K | ﹤0.01% |
+19,660
| New | +$348K |
|